Abstract
The crystal structure of the muscle relaxant stercuronium iodide in the form of its ethanol solvate C26H43N2 +I− · C2H5OH, has been determined by the heavy-atom method and refined by block-diagonal least-squares toR o = 0.062 for 1941 observed reflections andR = 0.079 for a total of 2420 reflections measured on a four-circle diffractometer in the ω/2θ scanning mode. The crystals are monoclinic,P21,a = 15.386(5),b = 11.377(4),c = 8.307(3) Å, β = 98.22(2) °,Z = 2. RingsA andB in the modified conessine skeleton are both highly symmetrical half-chairs, ringC is in the chair conformation, and ringsD andE are highly symmetrical envelopes. The pyrrolidine ringE fused to ringD is roughly perpendicular to the steroid skeleton formed by ringsA toD. The N+---N distance of 10.76 Å is within the usual range required for potent neuromuscular blocking. Semiquantitative results are presented which suggest that the site of the tertiary N atom in ringE is not heavily congested by neighboring atoms in the molecule and may therefore be susceptible to protonation under physiological conditions. This could account for the relatively high drug potency of stercuronium.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Barton, D. H. R., and Morgan, L. R. (1961)Proc. Chem. Soc. 206.
Barton, D. H. R., and Morgan, L. R. (1962)J. Chem. Soc. 622–631.
Bertho, A., and Götz, M. (1958)Liebigs Ann. Chem. 619, 96–121.
Bonta, I. L., and Goorissen, E. M. (1968)Eur. J. Pharmacol. 4, 303–308.
Buckett, W. R., Hewett, C. L., and Savage, D. S. (1967)Chim. Ther. 2, 186.
Buckett, W. R., Marjoribands, C. E. B., Marwick, F. A., and Morton, M. B. (1968)Br. J. Pharmacol. 32, 671–682.
Busfield, D., Child, K. J., Clarke, A. J., Davies, B., and Dodds, M. G. (1968)Br. J. Pharmacol. 32, 609–623.
Codding, P. W., and James, M. H. G. (1973)Acta Crysl. B 24, 435–942.
Cromer, D. T., and Liberman, D. (1970)J. Chem. Phys. 53, 1891–1898.
Duax, W. L., and Norton, D. A. (1975)Atlas of Steroid Structure (Plenum Press, New York and London).
Duax, W. L., Weeks, C. M., and Rohrer, D. C. (1976)Recent Prog. Horm. Res. 32, 81–116.
Everett, A. J., Lowe, L. A., and Wilkinson, S. (1970)Chem. Commun. 1020–1021.
Faure, H., Haworth, R. D., McKenna, J., Powell, R. G., and Whitfield, G. H. (1953)J. Chem. Soc. 1115–1129.
Fieser, L. F., and Fieser, M. (1959)Steroids (Reinhold, New York), pp. 857et seq.
Gandiha, A., Marshall, I. G., Paul, D., and Singh, H. (1974).J. Pharm. Pharmacol. 26, 871–877.
Gilmore, C. J., Bryan, R. F., and Kubchan, S. N. (1976) JACS98, 1947–1952.
Griffith, H. R., and Johnson, G. E. (1942)Anesthesiologv 3, 418–420.
Hamilton, W. E. (1965)Acta Cryst. 18, 502–510.
Haworth, R. D., McKenna, J., and Whitfield, G. H. (1953a)J. Chem. Soc. 1102–1109.
Haworth, R. D., McKenna, J., and Powell, R. G. (1953b)J. Chem. Soc. 1110–1115.
Hespe, W., and Wieriks, J. (1971) Biochem. Pharmacol.,20, 1213–1224.
Husain, J., Palmer, R. A., Singh, H., Bhardwaj, T. R., and Paul, D. (1981)Acta Cryst. B. 37, 205–209.
Kennard, O., Watson, D. G., and Allen, F. M. (1980), personal communication.
Kopfmann, G., and Huber, R. (1965)Acta Cryst. A 24, 348–351.
Marshall, I. G. (1973a)Eur. J. Pharmacol. 21, 299–304.
Marshall, I. G. (1973b)J. Pharm. Pharmacol. 25, 530–536.
Marshall, J. A., and Johnson, W. S. (1962)J. Am. Chem. Soc. 84, 1485–1486.
MacLagan, J. (1976) InNeuromuscular Junction, E. Zaimis, ed. (Springer-Verlag, Berlin, Heidelberg, and New York), Chapter 4B.
Mazid, M. A., Palmer, R. A., Singh, H., and Paul, D. (1977)Acta Cryst. B 33, 3641–3649.
Merck Index (8th edn.), E. Stecher, ed. (Merck and Co., Inc. Rahway, New Jersey).
Nagata, W., Terasawa, T., and Aoki, T. (1963)Tetrahedron Lett. 5, 869–871.
North, A. C. T., Phillips, D. C., and Mathews, F. S. (1968)Acta Cryst. A 24, 351–359.
Palmer, R. A., Kalam, M. A., Singh, H., and Paul D. (1980)J. Cryst. Mol. Struct.,10, 31–53.
Reynolds, C. D., Palmer, R. A., Gorinsky, B. A., and Gorinsky, C. (1975)Biochim. Biophys. Acta,404, 341–344.
Reynolds, C. D., and Palmer, R. A. (1976)Acta Cryst. B 32, 1431–1439.
Savage, D. S., Cameron, A. F., Ferguson, G., Hannaway, C., and Mackay, I. R. (1971)J. Chem. Soc. B 410–415.
Singh, H., and Paul, D. (1974)J. Chem. Soc. Perkin Trans, 1 1475–1479.
Singh, H., Paul, D., and Parasher, V. V. (1973)J. Chem. Soc. Perkin Trans, 1 1204–1206.
Stork, G., Darling, S. D., Harrison, I. T., and Wharton, P. S. (1962)J. Am. Chem. Soc. 84, 2018–2020.
Teerapong, P., Marshall, I. G., Harvey, A. L., Singh, H., Paul, D., Bhardwaj, T. R., and Ahua, N. K. (1979).J. Pharm. Pharmacol. 28, 521–528.
Tickle, I. J. (1975)Acta Cryst. B 31, 329–331.
Tickle, I. J. (1979) Personal Communication.
Watkin, D. J., (1972)Acta Cryst. A 28, 33–35.
Wieriks, J. (1972), Ph.D. Thesis, University of Rotterdam.
Wipke, W. T., and Gund, P. (1974).J. Am. Chem. Soc. 96, 299–301.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Husain, J., Palmer, R.A. & Tickle, I.J. Crystal and molecular structure of stercuronium iodide ethanol solvate: A peripheral muscle relaxant. Journal of Crystal and Molecular Structure 11, 87–103 (1981). https://doi.org/10.1007/BF01200883
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01200883